Liu Sheng-Yao, Deng Song-Yun, He Yong-Bin, Ni Guo-Xin
Department of Orthopeadics and Traumatology, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue (N), Guangzhou 510515, China.
Department of Orthopeadics and Traumatology, Nanfang Hospital, Southern Medical University, 1838 Guangzhou Avenue (N), Guangzhou 510515, China; Department of Rehabilitation Medicine, First Affiliated Hospital, Fujian Medical University, 20 Chazhong Road, Fuzhou 350005, China.
Biochem Biophys Res Commun. 2017 Jan 22;482(4):987-993. doi: 10.1016/j.bbrc.2016.11.145. Epub 2016 Nov 28.
Osteosarcoma (OS) has become one of the most common primary malignant tumors in the children and adolescents with a poor prognosis owing to its high malignant and metastatic potential. Although increasing evidence indicates that miR-451 could inhibit the growth and metastasis of OS, its effect on angiogenesis in OS is still very poor. What is more, the mechanism by which miR-451 affects the OS has not been fully elucidated. In the present study, miR-451 was reduced in human osteosarcoma tissues compared with the adjacent bone tissues, and the introduction of miR-451 dramatically inhibited the growth, migration and angiogenesis in OS. Additionally, it was suggested that IL 6R is a direct target gene of miR-451. Silencing of IL 6R suppressed the growth, migration and angiogenesis of OS, which was consistent with the effect of overexpression of miR-451. In conclusion, our data demonstrate that miR-451 may function as a potential suppressor of tumor growth, migration and angiogenesis in OS via down-regulating IL 6R, suggesting a promising therapeutic avenue for managing OS.
骨肉瘤(OS)已成为儿童和青少年中最常见的原发性恶性肿瘤之一,由于其高恶性和转移潜能,预后较差。尽管越来越多的证据表明miR-451可以抑制骨肉瘤的生长和转移,但其对骨肉瘤血管生成的影响仍然知之甚少。此外,miR-451影响骨肉瘤的机制尚未完全阐明。在本研究中,与相邻骨组织相比,人骨肉瘤组织中miR-451表达降低,导入miR-451可显著抑制骨肉瘤的生长、迁移和血管生成。此外,研究表明IL-6R是miR-451的直接靶基因。沉默IL-6R可抑制骨肉瘤的生长、迁移和血管生成,这与过表达miR-451的效果一致。总之,我们的数据表明,miR-451可能通过下调IL-6R作为骨肉瘤肿瘤生长、迁移和血管生成的潜在抑制因子,为骨肉瘤的治疗提供了一条有前景的治疗途径。